Form 4: NeuroMetrix Director Van Avermaete Disposes of Shares and Restricted Stock Units Following Merger

Director David Van Avermaete reports the disposal of common stock and restricted stock units due to the merger between NeuroMetrix, Inc. and electroCore, Inc.

Summary

• David Van Avermaete, a director of NeuroMetrix, Inc., reported the disposal of common stock and restricted stock units on May 1, 2025, following the merger with electroCore, Inc.
• The transactions were executed as per the Agreement and Plan of Merger dated December 17, 2024.
• Each share of NeuroMetrix common stock was converted into the right to receive a pro rata share of the company's net cash and one contingent value right (CVR).
• Each restricted stock unit (RSU) was converted into the right to receive cash and CVRs based on the number of underlying shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction following a merger. There are no indications of positive or negative performance, just the execution of a pre-defined agreement.

Future Outlook

The document does not contain specific forward-looking statements beyond the completion of the merger.

Industry Context

This announcement reflects a merger and acquisition activity within the medical technology sector, where companies often consolidate to achieve synergies, expand market reach, or acquire new technologies.

Comparison to Industry Standards

• Mergers and acquisitions are common in the medical technology industry, with companies like Medtronic and Boston Scientific frequently acquiring smaller firms to bolster their product portfolios.
• Contingent Value Rights (CVRs) are sometimes used in M&A deals to bridge valuation gaps and align the interests of the acquiring and acquired companies, similar to deals seen in the pharmaceutical industry.

Stakeholder Impact

• Shareholders received cash and CVRs as part of the merger agreement.
• Employees with RSUs also received cash and CVRs based on their holdings.

Key Dates

Keywords

Merger, NeuroMetrix, electroCore, Form 4, Director, Van Avermaete, Common Stock, Restricted Stock Units, CVR, Disposal